1. Home
  2. BRSP vs PRTA Comparison

BRSP vs PRTA Comparison

Compare BRSP & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRSP
  • PRTA
  • Stock Information
  • Founded
  • BRSP 2017
  • PRTA 2012
  • Country
  • BRSP United States
  • PRTA Ireland
  • Employees
  • BRSP N/A
  • PRTA N/A
  • Industry
  • BRSP Real Estate Investment Trusts
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRSP Real Estate
  • PRTA Health Care
  • Exchange
  • BRSP Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • BRSP 730.1M
  • PRTA 643.0M
  • IPO Year
  • BRSP 2018
  • PRTA N/A
  • Fundamental
  • Price
  • BRSP $5.71
  • PRTA $14.11
  • Analyst Decision
  • BRSP Hold
  • PRTA Buy
  • Analyst Count
  • BRSP 5
  • PRTA 7
  • Target Price
  • BRSP $7.06
  • PRTA $46.50
  • AVG Volume (30 Days)
  • BRSP 631.6K
  • PRTA 672.2K
  • Earning Date
  • BRSP 02-19-2025
  • PRTA 02-13-2025
  • Dividend Yield
  • BRSP 11.28%
  • PRTA N/A
  • EPS Growth
  • BRSP N/A
  • PRTA N/A
  • EPS
  • BRSP N/A
  • PRTA N/A
  • Revenue
  • BRSP $378,095,000.00
  • PRTA $133,350,000.00
  • Revenue This Year
  • BRSP N/A
  • PRTA $56.89
  • Revenue Next Year
  • BRSP N/A
  • PRTA N/A
  • P/E Ratio
  • BRSP N/A
  • PRTA N/A
  • Revenue Growth
  • BRSP N/A
  • PRTA N/A
  • 52 Week Low
  • BRSP $5.07
  • PRTA $11.70
  • 52 Week High
  • BRSP $7.71
  • PRTA $34.65
  • Technical
  • Relative Strength Index (RSI)
  • BRSP 43.81
  • PRTA 50.40
  • Support Level
  • BRSP $5.40
  • PRTA $13.00
  • Resistance Level
  • BRSP $5.85
  • PRTA $14.40
  • Average True Range (ATR)
  • BRSP 0.15
  • PRTA 0.99
  • MACD
  • BRSP 0.01
  • PRTA 0.04
  • Stochastic Oscillator
  • BRSP 51.69
  • PRTA 59.11

About BRSP BrightSpire Capital Inc.

BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Share on Social Networks: